Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 17, 2026 08:00 ET | Source: 4D Molecular Therapeutics, Inc.

4DMT Announces New Employment Inducement Grants

EMERYVILLE, Calif., Jan. 17, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted...
January 17, 2026 04:00 ET | Source: Micron Technology, Inc.

Micron Signs Letter of Intent to Purchase Tongluo Site, Begin Strategic Partnership with PSMC

BOISE, Idaho, Jan. 17, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced it has signed an exclusive Letter of Intent (LOI) to acquire Powerchip Semiconductor...
January 16, 2026 19:01 ET | Source: ArrowMark Financial Corp.

ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of December 2025

DENVER, Jan. 16, 2026 (GLOBE NEWSWIRE) -- ArrowMark Financial Corp., (NASDAQ: BANX) ("ArrowMark Financial"), today announced that BANX’s estimated and unaudited Net Asset Value (“NAV”) as of...
January 16, 2026 18:15 ET | Source: GBank Financial Holdings Inc.

GBank Financial Holdings Inc. Announces Fourth Quarter 2025 Quarterly Earnings Call Scheduled for Wednesday, January 28th, at 2:00 P.M., Pacific Time

LAS VEGAS, Jan. 16, 2026 (GLOBE NEWSWIRE) -- GBank Financial Holdings Inc. (the "Company") (Nasdaq: GBFH), the parent company for GBank (the "Bank"), today announced it plans to release its fourth...
January 16, 2026 18:11 ET | Source: DBV Technologies S.A.

DBV Technologies annonce avoir reçu un produit brut de 166,7 millions d'euros suite à l'exercice intégral des Bons de Souscription (BS) issus des ABSAs et des BS issus des PFW-BS-PFW émis dans le cadre de son financement de mars 2025

Châtillon, France, 16 janvier 2026 DBV Technologies annonce avoir reçu un produit brut de 166,7 millions d'euros suite à l'exercice intégral des Bons de Souscription (BS) issus des ABSAs et des BS...
January 16, 2026 18:11 ET | Source: DBV Technologies S.A.

DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing

Châtillon, France, January 16, 2026 DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing ...
January 16, 2026 17:15 ET | Source: Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and...
January 16, 2026 17:05 ET | Source: Annexon Biosciences

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at...
January 16, 2026 16:55 ET | Source: Aduro Clean Technologies Inc.

Aduro Clean Technologies gibt Ergebnisse für das zweite Quartal des Geschäftsjahres 2026 bekannt und informiert über den aktuellen Stand des Geschäfts

LONDON, Ontario, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro“ oder das „Unternehmen“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Unternehmen für umweltfreundliche...
January 16, 2026 16:55 ET | Source: Aduro Clean Technologies Inc.

Aduro Clean Technologies présente les résultats financiers de son deuxième trimestre 2026 et fait le point sur ses activités

LONDON, Province de l’Ontario, 16 janv. 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc., ci-après « Aduro » ou la « Société » (Nasdaq : ADUR) (CSE : ACT) (FSE : 9D5), une société de...